• KEEP LIFE FLOWING

    Kedrion’s plasma-derived therapies help people suffering from debilitating conditions like Hemophilia and Immune Deficiencies. We are privileged to provide this service and do so with a profound sense of responsibility.

  • KEEP LIFE FLOWING

    Kedrion’s plasma-derived therapies help people suffering from debilitating conditions like Hemophilia and Immune Deficiencies. We are privileged to provide this service and do so with a profound sense of responsibility.

  • KEEP LIFE FLOWING

    Kedrion’s plasma-derived therapies help people suffering from debilitating conditions like Hemophilia and Immune Deficiencies. We are privileged to provide this service and do so with a profound sense of responsibility.

NEWS

The world of Kedrion Biopharma at a glance:
discover the latest
up-to-date news.

20-01-2022
Permira to partner with Marcucci family to invest in Kedrion and BPL
Read all
18-01-2022
Kedrion in Turkey: ever closer to patients
In 2021, the company committed to strengthening its presence in the country
Read all
18-10-2021
Kedrion grows in North America as it completes acquisition of Prometic
Launch is planned for the first ever FDA-approved treatment for patients suffering from Congenital Plasminogen Deficiency
Read all
2020 Annual report
Pharmacovigilance
Medical & Scientific Information
VIDEO-GALLERY